Obstructive Sleep Apnea (OSA) is a sleep disorder characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep, leading to breathing pauses (apneas) or reduced airflow (hypopneas). This results in disrupted sleep, loud snoring, daytime fatigue, and potential health complications like high blood pressure, heart disease, or stroke if untreated. It is often associated with factors like obesity, anatomical airway issues, or relaxed throat muscles.. Obstruct
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age over 18 years Mild to moderate obstructive sleep apnea Unwillingness to use CPAP device or undergo surgery
Exclusion criteria
Exclusion criteria: BMI > 35 Symptomatic nasal pathology (e.g., deviated nasal septum, nasal polyps, or chronic rhinosinusitis) Tonsillar hypertrophy (tonsil size grade 3 or higher) Tongue or lip piercing Use of a pacemaker or implanted medical electrical devices Previous oral surgery for snoring Facial skeletal abnormalities related to the study (e.g., syndromic facial defects or severe micrognathia) Any oral disease/abnormal condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improving obstructive sleep apnea. Timepoint: Baseline: Before the intervention begins (prior to the 6-week treatment period).Post-intervention: Immediately after the completion of the 6-week treatment period. Method of measurement: Polysomnography (PSG): A comprehensive sleep study conducted to objectively measure Snore Index, Snore Time, AHI, and ODI. Questionnaires: Epworth Sleepiness Scale (ESS) , and Pittsburgh Sleep Quality Index (PSQI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences